Literature DB >> 11207634

Determinants of changes in plasma homocysteine in hyperthyroidism and hypothyroidism.

M J Diekman1, N M van der Put, H J Blom, J G Tijssen, W M Wiersinga.   

Abstract

OBJECTIVE: Hyperhomocysteinaemia is a risk factor for premature atherosclerotic vascular disease and venous thrombosis. The aim of the present study was to assess plasma total homocysteine (tHCys) concentrations in hypo- as well as hyperthyroid patients before and after treatment, and to evaluate the role of potential determinants of plasma tHCys levels in these patients.
DESIGN: Prospective follow up study. PATIENTS: Fifty hypothyroid and 46 hyperthyroid patients were studied in the untreated state and again after restoration of euthyroidism. MEASUREMENTS: Fasting plasma levels of tHCys and its putative determinants (plasma levels of free thyroxine (fT4), folate, vitamin B(12), renal function, sex, age, smoking status and the C677T polymorphism in the methylenetetrahydrofolate reductase (MTHFR) gene were measured before and after treatment.
RESULTS: Restoration of the euthyroid state decreased both tHCys (17.6 +/- 10.2-13.0 +/- 4.7 micromol/l; P < 0.005) and creatinine (83.9 +/- 22.0-69.8 +/- 14.2 micromol/l; P < 0.005) in hypothyroid patients and increased both tHCys (10.7 +/- 2.5-13.4 +/- 3.3 micromol/l; P < 0.005) and creatinine (49.0 +/- 15.4-66.5 +/- 15.0 micromol/l; P < 0.005) in hyperthyroid patients (values as mean +/- SD). Folate levels were lower in the hypothyroid group compared to the hyperthyroid group (11.7 +/- 6.4 and 15.1 +/- 7.6 nmol/l; P < 0.05). Pretreatment tHCys levels correlated with log fT(4) (r = - 0.47), folate (r = - 0.21), plasma creatinine (r = 0.45) and age (r = 0.35) but not with C677T genotype. Multivariate analysis indicated that pretreatment log(fT(4)) levels and age accounted for 28% the variability of pre-treatment tHCys (tHCys = 14.2-5.50 log(fT(4)) + 0.14 age). After treatment the logarithm of the change (Delta) in fT(4) (expressed as the post-treatment fT(4)/pre-treatment fT(4) ratio) accounted for 45% of the variability in change of tHCys ( tHCys = - 0.07-4.94 log ( fT(4))); there was no independent contribution of changes in creatinine which was, however, strongly related to changes in tHCys (r = 0.61).
CONCLUSIONS: Plasma tHCys concentrations increased in hypothyroidism and decreased in hyperthyroidism. Plasma fT(4) is an independent determinant of tHCys concentrations. Lower folate levels and a lower creatinine clearance in hypo-thyroidism, and a higher creatinine clearance in hyperthyroidism only partially explain the changes in tHCys.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11207634     DOI: 10.1046/j.1365-2265.2001.01170.x

Source DB:  PubMed          Journal:  Clin Endocrinol (Oxf)        ISSN: 0300-0664            Impact factor:   3.478


  12 in total

1.  Effects of folic acid plus levothyroxine on serum homocysteine level in hypothyroidism.

Authors:  Amir Ziaee; Nader Hajibagher Tehrani; Zahra Hosseinkhani; Amir Kazemifar; Amir Javadi; Toktam Karimzadeh
Journal:  Caspian J Intern Med       Date:  2012

2.  Hypothyroidism and cerebral vein thrombosis--a possible association.

Authors:  Ana Rita Peralta; Patrícia Canhão
Journal:  J Neurol       Date:  2008-06-20       Impact factor: 4.849

Review 3.  Hypothyroidism as a risk factor for cardiovascular disease.

Authors:  Bernadette Biondi; Irwin Klein
Journal:  Endocrine       Date:  2004-06       Impact factor: 3.633

Review 4.  Thyroid hormones and heart failure.

Authors:  Felipe Martinez
Journal:  Heart Fail Rev       Date:  2016-07       Impact factor: 4.214

5.  Role of surrogate markers of atherosclerosis in clinical and subclinical thyroidism.

Authors:  Mehmet Gunduz; Ercan Gunduz; Fatih Kircelli; Nazan Okur; Mesut Ozkaya
Journal:  Int J Endocrinol       Date:  2012-02-23       Impact factor: 3.257

6.  Association between Hyperhomocysteinemia and Thyroid Hormones in Euthyroid Diabetic Subjects.

Authors:  Yun Zhang; Qiong Wang; Quanzhong Li; Ping Lu
Journal:  Biomed Res Int       Date:  2015-06-21       Impact factor: 3.411

7.  Relationship between total homocysteine, total cholesterol and creatinine levels in overt hypothyroid patients.

Authors:  Saleh A Bamashmoos; Mohammed Ak Al-Nuzaily; Ali M Al-Meeri; Faisal Hh Ali
Journal:  Springerplus       Date:  2013-08-30

8.  Effect of leucovorin (folinic acid) on the developmental quotient of children with Down's syndrome (trisomy 21) and influence of thyroid status.

Authors:  Henri Blehaut; Clotilde Mircher; Aimé Ravel; Martine Conte; Veronique de Portzamparc; Gwendael Poret; Françoise Huon de Kermadec; Marie-Odile Rethore; Franck G Sturtz
Journal:  PLoS One       Date:  2010-01-11       Impact factor: 3.240

9.  Homocysteine and fibrinogen changes with L-thyroxine in subclinical hypothyroid patients.

Authors:  Başak Cakal; Erman Cakal; Berrin Demirbaş; Mesut Ozkaya; Selma Karaahmetoğlu; Rüştü Serter; Yalçin Aral
Journal:  J Korean Med Sci       Date:  2007-06       Impact factor: 2.153

10.  Serum homocysteine levels are decreased in levothyroxine-treated women with autoimmune thyroiditis.

Authors:  Maciej Owecki; Jolanta Dorszewska; Nadia Sawicka-Gutaj; Anna Oczkowska; Michał K Owecki; Michał Michalak; Jakub Fischbach; Wojciech Kozubski; Marek Ruchała
Journal:  BMC Endocr Disord       Date:  2014-03-01       Impact factor: 2.763

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.